Jak2 tyrosine kinase and cancer: how good cells get HiJAKed.

Anticancer Agents Med Chem

Department of Physiology and Functional Genomics, University of Florida College of Medicine, P.O. Box 100274, Gainesville, FL 32610, USA.

Published: November 2007

Cloned in 1992, Jak2 tyrosine kinase has emerged as a critical molecule in mammalian development, physiology, and disease. Here, we will review the early history of Jak2 as it pertains to its role in classical cellular signaling. We also review how specific structural determinants within Jak2 dictate its overall function. Finally, we will review relatively recent literature as it pertains to the role of Jak2 in neoplastic growth as well as the identification of novel Jak2 inhibitors. It is our hope that by reviewing these specific areas, we will have a better understanding of the role of Jak2 in cancer, and in turn, we may have a better idea as to how to block aberrant Jak2 function.

Download full-text PDF

Source
http://dx.doi.org/10.2174/187152007782330105DOI Listing

Publication Analysis

Top Keywords

jak2
8
jak2 tyrosine
8
tyrosine kinase
8
will review
8
pertains role
8
role jak2
8
kinase cancer
4
cancer good
4
good cells
4
cells hijaked
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!